AI Engines For more Details: Perplexity Kagi Labs You
Cardiovascular Health: Nattokinase has been studied for its potential to support cardiovascular health by promoting healthy blood circulation and reducing the risk of blood clots. It works by breaking down fibrin, a protein involved in blood clot formation, which may help prevent the formation of abnormal blood clots that can lead to conditions such as deep vein thrombosis (DVT), pulmonary embolism, and stroke.
Blood Pressure Regulation: Some research suggests that nattokinase may have beneficial effects on blood pressure regulation. It may help lower blood pressure by promoting vasodilation (relaxation of blood vessels) and improving blood flow, which can reduce the workload on the heart and lower the risk of hypertension (high blood pressure).
Reduced Risk of Stroke: Nattokinase's ability to break down fibrin may help reduce the risk of ischemic stroke, which occurs when a blood clot blocks blood flow to the brain. By preventing the formation of blood clots or dissolving existing clots, nattokinase may help maintain cerebral blood flow and reduce the risk of stroke, particularly in individuals at risk of thrombotic events.
Improved Circulation: Nattokinase supplementation has been associated with improved microcirculation, which refers to the flow of blood through small blood vessels such as capillaries. Enhanced microcirculation can improve oxygen and nutrient delivery to tissues and organs, promoting overall cardiovascular and metabolic health.
Anti-inflammatory Effects: Nattokinase may possess anti-inflammatory properties, which could contribute to its cardiovascular benefits. Chronic inflammation is a key factor in the development of cardiovascular diseases such as atherosclerosis, and reducing inflammation can help protect blood vessels and reduce the risk of cardiovascular events.
Potential Benefits for Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE): Nattokinase supplementation has been studied as a potential therapy for preventing and treating conditions such as deep vein thrombosis (DVT) and pulmonary embolism (PE), which are characterized by the formation of blood clots in the veins. By promoting fibrinolysis (breakdown of fibrin), nattokinase may help dissolve existing clots and prevent the recurrence of thrombotic events.
| Rank | Probiotic | Impact |
|---|
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
| Taxonomy | Rank | Effect | Citations | Notation |
|---|
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
| Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
|---|
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.